VYNE - VYNE Therapeutics Inc
0.6
-0.002 -0.300%
Share volume: 172,098
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.60
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 08-14-2025 | |
| Assets | |||||||
| Total Assets | 91.676 M | 86.648 M | 76.198 M | 66.905 M | 56.423 M | 44.718 M | |
| Current Assets | 90.223 M | 83.776 M | 73.535 M | 64.437 M | 54.913 M | 44.343 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.219 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 4.219 M | 48.492 M | 53.913 M | 41.590 M | 22.063 M | 17.600 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 85.950 M | 29.609 M | 16.272 M | 19.926 M | 28.209 M | 22.047 M | |
| Total Non-current Assets | 1.453 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 113.000 K | 107.000 K | 102.000 K | |
| Other Assets | 1.453 M | 2.872 M | 2.663 M | 2.355 M | 1.403 M | 273.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 91.676 M | 86.648 M | 76.198 M | 66.905 M | 56.423 M | 44.718 M | |
| Total liabilities | 8.306 M | 11.779 M | 12.661 M | 14.819 M | 12.291 M | 5.836 M | |
| Total current liabilities | 6.930 M | 11.754 M | 12.661 M | 14.819 M | 12.291 M | 5.836 M | |
| Accounts Payable | 2.795 M | 4.516 M | 3.986 M | 2.707 M | 3.534 M | 1.414 M | |
| Other liabilities | 1.313 M | 25.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 117.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 63.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.313 M | 25.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 83.370 M | 74.869 M | 63.537 M | 52.086 M | 44.132 M | 38.882 M | |
| Common stock | 42.581 M | 781.918 M | 782.651 M | 783.236 M | 783.913 M | 784.420 M | |
| Retained earnings | -697.585 M | -706.991 M | -719.148 M | -731.170 M | -739.781 M | -745.536 M |